This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 105/8/793    most recent CIRCRESAHA.109.200568v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Google Scholar Articles by Srivastava, S. Articles by Bhatnagar, A. PubMed PubMed Citation Articles by Srivastava, S. Articles by Bhatnagar, A. Related Collections Animal models of human disease Pathophysiology Energy metabolism

(Circulation Research. 2009;105:793.)
© 2009 American Heart Association, Inc.

Integrative Physiology

Aldose Reductase Protects Against Early Atherosclerotic Lesion Formation in Apolipoprotein E-Null Mice

Sanjay Srivastava, Elena Vladykovskaya, Oleg A. Barski, Matthew Spite, Karin Kaiserova, J. Mark Petrash, Stephen S. Chung, Greg Hunt, Buddhadeb Dawn, Aruni Bhatnagar

From the Diabetes and Obesity Center (S.S., E.V., O.A.B., M.S., K.K., G.H., B.D., A.B.), Institute of Molecular Cardiology, University of Louisville, Ky; Department of Ophthalmology (J.M.P.), Washington University, St Louis, Mo; and Department of Anatomy (S.S.C.), University of Hong Kong.

Correspondence to Sanjay Srivastava, PhD, Division of Cardiovascular Medicine, Department of Medicine, Delia Baxter Building, 580 S Preston St, Room 421B, University of Louisville, Louisville, KY 40202. E-mail sanjay{at}louisville.edu

Rationale: Atherosclerotic lesion formation is associated with the accumulation of oxidized lipids. Products of lipid oxidation, particularly aldehydes, stimulate cytokine production and enhance monocyte adhesion; however, their contribution to atherosclerotic lesion formation remains unclear.

Objective: To test the hypothesis that inhibition of aldehyde removal by aldose reductase (AR), which metabolizes both free and phospholipid aldehydes, exacerbates atherosclerotic lesion formation.

Methods and Results: In atherosclerotic lesions of apolipoprotein (apo)E-null mice, AR protein was located in macrophage-rich regions and its abundance increased with lesion progression. Treatment of apoE-null mice with AR inhibitors sorbinil or tolrestat increased early lesion formation but did not affect the formation of advanced lesions. Early lesions of AR^–/–/apoE^–/– mice maintained on high-fat diet were significantly larger when compared with age-matched AR^+/+/apoE^–/– mice. The increase in lesion area attributable to deletion of the AR gene was seen in both male and female mice. Pharmacological inhibition or genetic ablation of AR also increased the lesion formation in male mice made diabetic by streptozotocin treatment. Lesions in AR^–/–/apoE^–/– mice exhibited increased collagen and macrophage content and a decrease in smooth muscle cells. AR^–/–/apoE^–/– mice displayed a greater accumulation of the AR substrate 4-hydroxy trans-2-nonenal (HNE) in the plasma and protein-HNE adducts in arterial lesions than AR^+/+/apoE^–/– mice.

Conclusions: These observations indicate that AR is upregulated in atherosclerotic lesions and it protects against early stages of atherogenesis by removing toxic aldehydes generated in oxidized lipids.

Key Words: lipid peroxidation • aldehydes • atherosclerosis • oxidative stress • macrophage

This article has been cited by other articles:

				B. G. Hill and A. Bhatnagar Beyond Reactive Oxygen Species: Aldehydes as Arbitrators of Alarm and Adaptation Circ. Res., November 20, 2009; 105(11): 1044 - 1046. [Full Text] [PDF]